AGAPE ATP CORPORATION Revenue from Contract with Customer, Excluding Assessed Tax
AGAPE ATP CORPORATION (ATPC) reported Revenue from Contract with Customer, Excluding Assessed Tax of $13.69 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Revenue
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax · last filed 2026-08-14
- AGAPE ATP CORPORATION revenue from contract with customer, excluding assessed tax for the quarter ending 2026-06-30 was $13.69K, a 93.39% decline year-over-year.
- AGAPE ATP CORPORATION revenue from contract with customer, excluding assessed tax for the quarter ending 2026-03-31 was $273.66K, a 5.32% decline year-over-year.
- AGAPE ATP CORPORATION revenue from contract with customer, excluding assessed tax for the quarter ending 2025-12-31 was $399.13K, a 10.94% increase year-over-year.
- AGAPE ATP CORPORATION revenue from contract with customer, excluding assessed tax for the quarter ending 2025-09-30 was $370.59K, a 11.86% increase year-over-year.
- AGAPE ATP CORPORATION revenue from contract with customer, excluding assessed tax for fiscal 2025 was $1.52M, a 15.23% increase from fiscal 2024.
- AGAPE ATP CORPORATION revenue from contract with customer, excluding assessed tax for fiscal 2024 was $1.32M, a 7.57% decline from fiscal 2023.
- AGAPE ATP CORPORATION revenue from contract with customer, excluding assessed tax for fiscal 2023 was $1.43M, a 22.92% decline from fiscal 2022.
- AGAPE ATP CORPORATION revenue from contract with customer, excluding assessed tax for fiscal 2022 was $1.86M, a 82.56% increase from fiscal 2021.
| Period end | Revenue from Contract with Customer, Excluding Assessed Tax 3 month | Revenue from Contract with Customer, Excluding Assessed Tax 3 month as first filed | Revenue from Contract with Customer, Excluding Assessed Tax 6 month | Revenue from Contract with Customer, Excluding Assessed Tax 6 month as first filed | Revenue from Contract with Customer, Excluding Assessed Tax 9 month | Revenue from Contract with Customer, Excluding Assessed Tax 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13.69K 10-Q · filed 2026-08-14 | $35.28K 10-Q · filed 2026-08-14 | $686.48K derived: sum of 3 quarters · filed 2026-08-14 | $1.06M derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2026-03-31 | $273.66K 10-Q · filed 2026-05-15 | $672.79K derived: sum of 2 quarters · filed 2026-05-15 | $1.04M derived: sum of 3 quarters · filed 2026-05-15 | $1.25M derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2025-12-31 | $399.13K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-13 | $769.73K derived: sum of 2 quarters · filed 2026-04-13 | $976.75K derived: sum of 3 quarters · filed 2026-08-14 | $1.52M 10-K · filed 2026-04-13 | ||
| 2025-09-30 | $370.59K 10-Q · filed 2025-11-13 | $577.62K derived: sum of 2 quarters · filed 2026-08-14 | $1.13M 10-Q · filed 2025-11-13 | $1.23M derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2025-06-30 | $207.03K 10-Q · filed 2026-08-14 | $465.50K 10-Q · filed 2025-08-13 | $243.82K 10-Q · filed 2026-08-14 | $754.54K 10-Q · filed 2025-08-13 | $855.84K derived: sum of 3 quarters · filed 2026-08-14 | $1.19M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $289.04K 10-Q · filed 2026-05-15 | $648.81K derived: sum of 2 quarters · filed 2026-05-15 | $980.10K derived: sum of 3 quarters · filed 2026-05-15 | $1.29M derived: sum of 4 quarters · filed 2026-05-15 | ||
| 2024-12-31 | $359.78K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-13 | $691.07K derived: sum of 2 quarters · filed 2026-04-13 | $1.00M derived: sum of 3 quarters · filed 2026-04-13 | $1.32M 10-K · filed 2026-04-13 | ||
| 2024-09-30 | $331.29K 10-Q · filed 2025-11-13 | $644.33K derived: sum of 2 quarters · filed 2025-11-13 | $962.97K 10-Q · filed 2025-11-13 | $1.35M derived: sum of 4 quarters · filed 2025-11-13 | ||
| 2024-06-30 | $313.04K 10-Q · filed 2025-08-13 | $631.68K 10-Q · filed 2025-08-13 | $1.02M derived: sum of 3 quarters · filed 2025-08-13 | $1.38M derived: sum of 4 quarters · filed 2025-08-13 | ||
| 2024-03-31 | $318.64K 10-Q · filed 2025-05-15 | $709.71K derived: sum of 2 quarters · filed 2025-05-15 | $1.07M derived: sum of 3 quarters · filed 2025-05-15 | $1.37M derived: sum of 4 quarters · filed 2025-05-15 | ||
| 2023-12-31 | $391.07K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $746.38K derived: sum of 2 quarters · filed 2025-03-31 | $1.05M derived: sum of 3 quarters · filed 2025-03-31 | $1.43M 10-K · filed 2025-03-31 | ||
| 2023-09-30 | $355.31K 10-Q · filed 2024-11-14 | $659.25K derived: sum of 2 quarters · filed 2024-11-14 | $1.04M 10-Q · filed 2024-11-14 | $1.43M derived: sum of 4 quarters · filed 2024-11-14 | ||
| 2023-06-30 | $303.94K 10-Q · filed 2024-08-14 | $684.70K 10-Q · filed 2024-08-14 | $1.07M derived: sum of 3 quarters · filed 2024-08-14 | $1.74M derived: sum of 4 quarters · filed 2024-08-14 | ||
| 2023-03-31 | $380.77K 10-Q · filed 2024-05-14 | $767.77K derived: sum of 2 quarters · filed 2024-05-14 | $1.43M derived: sum of 3 quarters · filed 2024-05-14 | $1.83M derived: sum of 4 quarters · filed 2024-05-14 | ||
| 2022-12-31 | $387.01K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $1.05M derived: sum of 2 quarters · filed 2024-04-01 | $1.45M derived: sum of 3 quarters · filed 2024-04-01 | $1.86M 10-K · filed 2024-04-01 | ||
| 2022-09-30 | $663.89K 10-Q · filed 2023-11-14 | $1.06M derived: sum of 2 quarters · filed 2023-11-14 | $1.47M 10-Q · filed 2023-11-14 | $1.68M derived: sum of 4 quarters · filed 2023-11-14 | ||
| 2022-06-30 | $396.71K 10-Q · filed 2023-08-14 | $805.67K 10-Q · filed 2023-08-14 | $1.02M derived: sum of 3 quarters · filed 2023-08-14 | $1.22M derived: sum of 4 quarters · filed 2023-08-14 | ||
| 2022-03-31 | $408.96K 10-Q · filed 2023-05-15 | $619.07K derived: sum of 2 quarters · filed 2023-05-15 | $820.36K derived: sum of 3 quarters · filed 2023-05-15 | $1.12M derived: sum of 4 quarters · filed 2023-05-15 | ||
| 2021-12-31 | $210.11K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $411.40K derived: sum of 2 quarters · filed 2023-03-31 | $715.18K derived: sum of 3 quarters · filed 2023-03-31 | $1.02M 10-K · filed 2023-03-31 | ||
| 2021-09-30 | $201.28K 10-Q · filed 2022-11-14 | $505.07K derived: sum of 2 quarters · filed 2022-11-14 | $806.85K 10-Q · filed 2022-11-14 | $1.32M derived: sum of 4 quarters · filed 2022-11-14 | ||
| 2021-06-30 | $303.79K 10-Q · filed 2022-08-11 | $605.57K 10-Q · filed 2022-08-11 | $1.12M derived: sum of 3 quarters · filed 2022-08-11 | $2.53M derived: sum of 4 quarters · filed 2022-08-11 | ||
| 2021-03-31 | $301.78K 10-Q · filed 2022-05-13 | $813.07K derived: sum of 2 quarters · filed 2022-07-05 | $2.23M derived: sum of 3 quarters · filed 2022-07-05 | $3.74M derived: sum of 4 quarters · filed 2022-07-05 | ||
| 2020-12-31 | $511.29K derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2022-07-05 | $1.92M derived: sum of 2 quarters · filed 2022-07-05 | $3.43M derived: sum of 3 quarters · filed 2022-07-05 | $3.43M 10-K/A · filed 2022-07-05 | ||
| 2020-09-30 | $1.41M 10-Q/A · filed 2022-07-05 | $2.92M derived: sum of 2 quarters · filed 2022-07-05 | $2.92M 10-Q/A · filed 2022-07-05 | |||
| 2020-06-30 | $1.51M 10-Q · filed 2021-08-13 | $1.51M 10-Q · filed 2021-08-13 | ||||
| 2019-12-31 | $192.63K derived: 10-K 6 month − 10-Q 3 month · filed 2020-03-27 | $429.36K 10-K · filed 2020-03-27 | ||||
| 2019-09-30 | $236.74K 10-Q · filed 2019-11-12 | |||||
| 2019-06-30 | $1.55M 10-K · filed 2020-03-27 | |||||
| 2019-03-31 | $464.30K 10-Q · filed 2020-05-14 | $734.22K derived: sum of 2 quarters · filed 2020-05-14 | $1.15M derived: sum of 3 quarters · filed 2020-05-14 | |||
| 2018-12-31 | $269.92K derived: 10-K 6 month − 10-Q 3 month · filed 2020-03-27 | $685.29K 10-K · filed 2020-03-27 | ||||
| 2018-09-30 | $415.37K 10-Q · filed 2019-11-12 | |||||
| 2018-06-30 | $487.00K 10-K · filed 2020-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |